| |
NewswireToday - /newswire/ -
Winston-Salem, NC, United States, 10/06/2009 - SmallCapReview.com a leading site for small cap information is adding Biomedical Technology Solutions (OTCBB: BMTL) to its list of stocks "On the Radar".
|
| |
Biomedical Technology Solutions (BMTL) provides safe and environmentally sound medical waste disposal equipment for sharps and red bag waste, commonly found in medical, dental, veterinary, nursing, assisted living, and other health care facilities.
BMTL sells sells the Demolizer® II through its wholly owned subsidiary Biomedical Technology Solutions, Inc. BMTL's patented Demolizer® Technology converts infectious biomedical waste into non-infectious material. BMTL's products provide biomedical waste treatment solutions for the over 1,000,000 low to medium volume medical waste generators in the US and a global market five times larger than the US.The Demolizer® II is the GREEN alternative to biomedical waste disposal. The device is the only patented, portable, and self-contained system able to process both sharps and typical red bag biomedical waste onsite. The processed waste is rendered sterile and discarded as common trash eliminating up to 100% of the cost associated with its disposal.
The Demolizer® II meets or exceeds all EPA and CDC guidelines and is approved or meets treatment requirements in 47 states after review by 78 governmental agencies. The device uses no chemicals or liquids, plugs into a normal outlet through a surge protector, and automatically records and prints state required documentation. The Demolizer® II provides a safer, more environmentally GREEN method for biomedical waste disposal.
In April of 2009, Frost & Sullivan recognized BMTL with the prestigious 2009 North American Frost & Sullivan Award for Product Innovation of the Year.
Features available at SmallCapReview.com include in-depth profiles of select Small-Cap/Penny Stocks as well as the most comprehensive and up to date news available on the small-cap market.
No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com has been compensated up three thousand five hundred dollars by a third party APS for its services with regards to Biomedical Technology Solutions.
|
editor[.]smallcapreview.com 
